Literature DB >> 8444080

Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.

B Glasbrenner1, P Malfertheiner, O Pieramico, S Klatt, R Riepl, H Friess, H Ditschuneit.   

Abstract

Gallbladder dynamics, cholecystokinin (CCK), and pancreatic polypeptide (PP) release were studied in 14 patients with chronic pancreatitis (CP) (2 females, 12 males; age range 24-56 years) and 12 control subjects (4 females, 8 males, 21-50 years). On day 1, gallbladder contractility was investigated after ceruletide intravenous infusion (2.5 ng/kg/min for 10 min). On day 2, a mixed standard test meal (1450 kJ) was administered orally. Gallbladder volume was assessed at three time intervals before (-30, -15, 0 min) and at 5, 10, 20, 30, 40, 50, 60, 80, 100 and 120 min after stimulation by means of ultrasonography. CCK and PP plasma levels were determined at each time interval. Exocrine pancreatic function was assessed using the pancreolauryl serum test (PLT). Six patients with CP had severe exocrine pancreatic insufficiency (EPI) (PLT < 1.8 micrograms/ml) with steatorrhea, eight patients had mild-moderate EPI. Fasting gallbladder volume was increased in CP (32.3 +/- 3.1 cm3) as compared to controls (20.5 +/- 1.2 cm3) (P < 0.01). Peak gallbladder contraction (percent of initial volume) in CP ranged from 5 to 55% (controls: 8-46%) following ceruletide and from 17 to 86% (controls: 27-80%) following the test meal (NS). There was no correlation between the degree of EPI according to PLT and peak gallbladder contraction. Gallbladder emptying in CP patients was not different from controls, although the postprandial CCK response was significantly impaired (P < 0.01). Postprandial PP response in CP was correlated with the PLT result (r = 0.78; P < 0.01) but not with gallbladder emptying or refilling time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444080     DOI: 10.1007/bf01316503

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Impaired pancreatic polypeptide secretion in chronic pancreatitis.

Authors:  A Sive; A I Vinik; S Van Tonder; A Lund
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

2.  Release of pancreatic polypeptide in humans by infusion of cholecystokinin.

Authors:  J Lonovics; S Guzman; P Devitt; K E Hejtmancik; R L Suddith; P L Rayford; J C Thompson
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

3.  Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?

Authors:  M B Koch; V L Go; E P DiMagno
Journal:  Mayo Clin Proc       Date:  1985-04       Impact factor: 7.616

4.  Cholinergic regulation of PP release is mediated through muscarinic M1-receptors.

Authors:  J H Kleibeuker; J B Jansen; C B Lamers
Journal:  Digestion       Date:  1989       Impact factor: 3.216

5.  Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis.

Authors:  C Owyang; J H Scarpello; A I Vinik
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

6.  Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea.

Authors:  T E Adrian; H S Besterman; C N Mallinson; C Garalotis; S R Bloom
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

7.  Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.

Authors:  J B Jansen; W P Hopman; C B Lamers
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

8.  Fluorescein dilaurate serum test: a rapid tubeless pancreatic function test.

Authors:  P Malfertheiner; M Büchler; A Müller; H Ditschuneit
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

9.  Role of the small intestine and gastric antrum in pancreatic polypeptide release.

Authors:  I L Taylor; G L Kauffman; J H Walsh; H Trout; P Chew; J W Harmon
Journal:  Am J Physiol       Date:  1981-05

10.  Pancreatic polypeptide release stimulated by food, secretin and cholecystokinin in chronic pancreatitis.

Authors:  P Linnestad; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  1983-05       Impact factor: 2.423

View more
  5 in total

1.  Effect of oral protease inhibitor administration on gallbladder motility in patients with mild chronic pancreatitis.

Authors:  M Sugiyama; Y Atomi; N Wada; A Kuroda; T Muto
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

2.  Postprandial cholecystokinin response in patients with chronic pancreatitis in treatment with oral substitutive pancreatic enzymes.

Authors:  M C Garcés; J Gómez-Cerezo; R Codoceo; C Grande; J Barbado; J J Vázquez
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

3.  Gallbladder emptying in patients with primary sclerosing cholangitis.

Authors:  Karouk Said; Nick Edsborg; Nils Albiin; Annika Bergquist
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

4.  Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.

Authors:  E H Eddes; M Verkijk; H A Gielkens; I Biemond; W Bemelman; C B Lamers; A A Masclee
Journal:  Int J Pancreatol       Date:  2001

5.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.